NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/04/2023
Back to search
Official data from USPTO
EXCELLERATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
EXCELLERATE
ST13
US500000097218163Class
1, 5
Filing
97218163
Registration
7020674
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
04/04/2023
Trademark type
Word
Nice classes
1, 5
Filing date
01/13/2022
Registration date
04/04/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/04/2023
Last transaction
04/04/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/31/2019
First use in commerce
07/31/2019
Drawing code
4
Owner type
03
Owner location
Minneapolis, MN, US
Examiner
CHANG, KATHERINE S
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
B. C. (pessoa física)
Representatives
Courtney Thompson FREDRIKSON & BYRON
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in the industry and science; cell culture media for laboratory use; cell culture media for scientific and research use; cell culture reagents for scientific and research use; biological preparations for use in industry and science; diagnostic preparations for scientific or research use; preservatives being chemical preparations for use scientific or research use; all of the foregoing excluding chemicals for use in the oil and gas industrysynthetic bone graft tissueproducts containing human and animal-derived tissues
Class 5
Culture media for cultivating human and animal cells for medical or clinical use; reagents and media for medical and veterinary diagnostic purposes; all of the foregoing excluding chemicals for use in the oil and gas industrysynthetic bone graft tissueproducts containing human and animal-derived tissues
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/03/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/02/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/01/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/27/2023
IUAF
USE AMENDMENT FILED
02/06/2023
EISU
TEAS STATEMENT OF USE RECEIVED
02/06/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/20/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/25/2022
PUBO
PUBLISHED FOR OPPOSITION
10/25/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/25/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/24/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/24/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/25/2022
GNRT
NON-FINAL ACTION E-MAILED
02/25/2022
CNRT
NON-FINAL ACTION WRITTEN
02/25/2022
DOCK
ASSIGNED TO EXAMINER
02/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/20/2022
NWAP
NEW APPLICATION ENTERED
01/17/2022
Continuous trademark protection
Get notified about every new filing that threatens EXCELLERATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.